Abstract:Autism spectrum disorder (ASD) affects a significant number of individuals worldwide with the prevalence continuing to grow. It is becoming clear that a large subgroup of individuals with ASD demonstrate abnormalities in mitochondrial function as well as gastrointestinal (GI) symptoms. Interestingly, GI disturbances are common in individuals with mitochondrial disorders and have been reported to be highly prevalent in individuals with co-occurring ASD and mitochondrial disease. The majority of individuals with ASD and mitochondrial disorders do not manifest a primary genetic mutation, raising the possibility that their mitochondrial disorder is acquired or, at least, results from a combination of genetic susceptibility interacting with a wide range of environmental triggers. Mitochondria are very sensitive to both endogenous and exogenous environmental stressors such as toxicants, iatrogenic medications, immune activation, and metabolic disturbances. Many of these same environmental stressors have been associated with ASD, suggesting that the mitochondria could be the biological link between environmental stressors and neurometabolic abnormalities associated with ASD. This paper reviews the possible links between GI abnormalities, mitochondria, and ASD. First, we review the link between GI symptoms and abnormalities in mitochondrial function. Second, we review the evidence supporting the notion that environmental stressors linked to ASD can also adversely affect both mitochondria and GI function. Third, we review the evidence that enteric bacteria that are overrepresented in children with ASD, particularly Clostridia spp., produce short-chain fatty acid metabolites that are potentially toxic to the mitochondria. We provide an example of this gut-brain connection by highlighting the propionic acid rodent model of ASD and the clinical evidence that supports this animal model. Lastly, we discuss the potential therapeutic approaches that could be helpful for GI symptoms in ASD and mitochondrial disorders. To this end, this review aims to help better understand the underlying pathophysiology associated with ASD that may be related to concurrent mitochondrial and GI dysfunction.

The Gut Microbiota and Oxidative Stress in Autism Spectrum Disorders (ASD)

The many faces of microbiota-gut-brain axis in autism spectrum disorder

Oxidative Stress in Autism Spectrum Disorder—Current Progress of Mechanisms and Biomarkers

Altered Gut Microbiome in Autism Spectrum Disorder: Potential Mechanism and Implications for Clinical Intervention

Alteration of Gut Microbiota: New Strategy for Treating Autism Spectrum Disorder

Oxidative Stress Marker Aberrations in Children with Autism Spectrum Disorder: a Systematic Review and Meta-Analysis of 87 Studies (N = 9109)

Role of oxidative stress in the pathogenesis of autism spectrum disorders

The Gut Microbiota and Autism Spectrum Disorders

Gastrointestinal dysfunction in autism spectrum disorder: the role of the mitochondria and the enteric microbiome

The Possible Role of the Microbiota-Gut-Brain-Axis in Autism Spectrum Disorder

Role of the Gut Microbiota in the Pathophysiology of Autism Spectrum Disorder: Clinical and Preclinical Evidence

Autonomic Nervous System Neuroanatomical Alterations Could Provoke and Maintain Gastrointestinal Dysbiosis in Autism Spectrum Disorder (ASD): A Novel Microbiome-Host Interaction Mechanistic Hypothesis

Potential Role of Epigenetics and Redox Signaling in the Gut–Brain Communication and the Case of Autism Spectrum Disorder

Changes of Gut Microbiota in Autism Spectrum Disorders and Common Probiotics & Chinese Herbal Medicine Therapeutic Mechanisms: a Review

Association Between Gut Microbiota and Autism Spectrum Disorder: A Systematic Review and Meta-Analysis.

Relationships between Gut Microbiota and Autism Spectrum Disorders: Development and Treatment

Gut microbiome and serum amino acid metabolome alterations in autism spectrum disorder

The Impact of Gut Microbiota-Derived Metabolites in Autism Spectrum Disorders

Alteration of Gut Microbiota-Associated Epitopes in Children with Autism Spectrum Disorders

A review of probiotics in the treatment of autism spectrum disorders: Perspectives from the gut–brain axis

Inflammation and Mitochondrial Dysfunction in Autism Spectrum Disorder